Wealth Enhancement Advisory Services LLC increased its stake in Tenet Healthcare Corporation (NYSE:THC – Free Report) by 13.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,661 shares of the company’s stock after buying an additional 3,629 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Tenet Healthcare were worth $6,390,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in the business. Wedmont Private Capital grew its stake in shares of Tenet Healthcare by 2.5% in the fourth quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock worth $422,000 after acquiring an additional 50 shares during the period. Sagespring Wealth Partners LLC increased its position in Tenet Healthcare by 3.6% in the fourth quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock worth $313,000 after buying an additional 55 shares in the last quarter. Crestwood Advisors Group LLC raised its position in shares of Tenet Healthcare by 2.5% during the 3rd quarter. Crestwood Advisors Group LLC now owns 2,606 shares of the company’s stock valued at $529,000 after purchasing an additional 64 shares during the period. Everpar Advisors LLC boosted its stake in shares of Tenet Healthcare by 5.9% in the fourth quarter. Everpar Advisors LLC now owns 1,230 shares of the company’s stock worth $244,000 after acquiring an additional 68 shares during the period. Finally, Andina Capital Management LLC grew its holdings in Tenet Healthcare by 2.1% during the 3rd quarter. Andina Capital Management LLC now owns 3,360 shares of the company’s stock valued at $682,000 after buying an additional 69 shares in the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities research analysts recently issued reports on the stock. KeyCorp upped their price target on shares of Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Thursday, February 12th. Morgan Stanley reiterated an “overweight” rating and set a $260.00 target price on shares of Tenet Healthcare in a research report on Thursday, February 12th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, March 1st. Royal Bank Of Canada increased their target price on shares of Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research report on Thursday, February 12th. Finally, Leerink Partners lifted their target price on shares of Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research note on Friday, February 20th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $250.56.
Insider Activity
In other news, EVP Thomas W. Arnst sold 24,000 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the transaction, the executive vice president owned 8,012 shares of the company’s stock, valued at approximately $1,875,128.48. The trade was a 74.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the sale, the executive vice president owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 46,517 shares of company stock worth $10,943,111. Corporate insiders own 0.81% of the company’s stock.
Tenet Healthcare Stock Performance
Tenet Healthcare stock opened at $192.01 on Friday. The stock has a market cap of $16.70 billion, a price-to-earnings ratio of 12.40, a price-to-earnings-growth ratio of 0.93 and a beta of 1.39. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $247.21. The firm has a 50 day simple moving average of $213.80 and a 200-day simple moving average of $205.19. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68.
Tenet Healthcare (NYSE:THC – Get Free Report) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current year.
Tenet Healthcare Profile
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Featured Stories
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
